Esophageal scintigraphy with a semisolid meal to evaluate esophageal dysmotility in systemic sclerosis and Raynaud's phenomenon

Journal of Nuclear Medicine

Volumn 40, Issue 1, 1999, Pages 77-84

  Bestetti, Alberto ^a   Carola, Federica ^a   Conciato, Luisa ^a   Marasini, Bianca ^a   Tarolo, Gian Luigi ^a  

^a SAN PAOLO HOSPITAL   (Italy)

Author keywords

Esophageal motility; Esophageal scintigraphy; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

DOMPERIDONE; OMEPRAZOLE; RANITIDINE; SUCRALFATE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS FUNCTION; ESOPHAGUS MOTILITY; ESOPHAGUS SCINTISCANNING; FEMALE; HEARTBURN; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS;

ADULT; AGED; DEGLUTITION; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERISTALSIS; RADIOPHARMACEUTICALS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0032898723     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Belch JJF. Raynaud's phenomenon. Curr Opin Rheum. 1990;2:937-941.
2. D'Angelo WA, Freis JF, Masi AT, et al. Pathologic observation in systemic sclerosis (scleroderma). Am J Med. 1969;46:428-440.
3. Folwaczny C, Voderholzer W, Riepl RL, Schindlbeck N. Clinical aspects, pathophysiology, diagnosis and therapy of gastrointestinal manifestations of progressive systemic scleroderma. Z Gastroenterol. 1996;34:497-508.
4. Taillefer R, Jadliwalla M, Pellerin E, Lafontaine E, Duranceau A. Radionuclide esophageal transit study in detection of esophageal motor dysfunction: comparison with motility studies (manometry). J Nucl Med. 1990;31:1921-1926.
5. Klein HA, Wald A, Graham TO, Campbell WL, Steen VD. Comparative studies of esophageal function in systemic sclerosis. Gastroenterology. 1992;102:1551-1556.
6. Tolin RD, Malmud LS, Reilley J, Fisher RS. Esophageal scintigraphy to quantitate esophageal transit (quantitation of esophageal transit). Gastroenterology. 1979;76: 1402-1408.
7. Russel COH, Hill LD, Holmes ER III, Hull DA, Gannon R, Pope CE II. Radionuclide transit: a sensitive screening test for esophageal dysfunction. Gastroenterology. 1981;80:887-92.
8. Maddem GJ, Horowitz M, Jamieson GG, Chatterton BE, Collins PJ, Roberts-Thomson P. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology. 1984;87:922-926.
9. Davidson A, Russell C, LittleJohn GO. Assessment of esophageal abnormalities in progressive systemic sclerosis using radionuclide transit. J Rheumatol. 1985;12: 472-477.
10. Carette S, Lacourciere Y, Lavoie S, Halle P. Radionuclide esophageal transit in progressive systemic sclerosis. J Rheumatol. 1985;21:478-181.
11. Drane WE, Kaevelis K, Johnson DA, Curran JJ, Silverman ED. Progressive systemic sclerosis: radionuclide esophageal scintigraphy and manometry. Radiology. 1986;160:73-76.
12. Åkesson A, Gustafson T, Wollheim F, Brismar J. Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis. J Rheumatol. 1987;16:291-299.
13. Edenbrandt L, Theander E, Högström M, Scheja A, Åkesson A. Palmer J. Esophageal scintigraphy of systemic sclerosis. J Nucl Med. 1995;36:1533-1538.
14. Kaye SA, Siray QH, Agnew J, Hilson A, Black CM. Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphic grading method. J Rheumatol. 1996;23:297-301.
15. Parkman H, Maurer A, Caroline D, et al. Optimal evaluation of patients with nonobstructive esophugeal dysphagia. Manometry, scintigraphy or videoesophagography? Dig Dis Sci. 1997;7:1355-1368.
16. Stevens MB, Hookman P, Siegel CI, Esterly JR, Shulman LE, Hendrix T. Aperistalsis of the esophagus in patients with connective-tissue disorders and Raynaud's phenomenon. N Engl J Med. 1964;270:1218-1222.
17. Belch JJF, Land D, Park RHR, et al. Decreased oesophageal blood flow in patients with Raynaud's phenomenon. Br J Rheumatol. 1988;27:426-430.
18. LeRoy EC, Black CM, Fleischmajer R, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202-205.
19. Klein HA. Esophageal transit scintigraphy. Semin in Nucl Med. 1995;25:306-317.
20. Luggen M, Belhorn L, Evans T, Fitzgerald O, Spencer-Green G. The evolution of Raynaud's phenomenon: a longterm prospective study. J Rheumatol. 1995;22: 2226-2232.
21. Kim CH, Hsu JJ. O'Connor MK, et al. Effect of viscosity on oropharyngeal and esophageal emptying in man. Dig Dis Sci. 1994;39:189-192.
22. Tatsch K, Schroettle W, Kirsch C. A multiple swallow test for the quantitative and qualitative evaluation of esophageal motility disorders. J Nucl Med. 1991;32:1365-1370.
23. Blackwell JN, Hannan WJ, Adam RD, et al. Radionuclide transit studies in the detection of esophageal dysmotility. Gut. 1983;24:421-426.
24. Llamas-Evira JM, Martinez-Parade M, Sopena-Monforte R, et al. Value of radionuclide oesophageal transit studies of functional dysphagia. Br J Radiol. 1986;59:1073-1078.
25. Klein HA, Wald A. Esophageal transit scintigraphy. Ann Nucl Med. 1988;1:79-124.